
IN THIS ISSUE...Paying More to Save More...Another Blockbuster Falls: Generic Plavix® Now Available...NOC Watch: Mozobil, Resotran...Protecting Your Plan from the Gravy Train. View post
IN THIS ISSUE...Look Out for 2012...Fighting the battle: Narcotic abuse Ontario...NOC Watch: Sublinox, Generic Latanoprost...FEATURE: The Story of Nexium®, Generic Esomeprazole and the Shortcoming of Mandatory Generic Substitution...Subsequent Entry Biologics: Expectations and Reality View post
IN THIS ISSUE...FEATURE: Breakthrough in the treatment of hepatitic C: treatment costs expected to more than double...Aspirin Falling Out of Favour?...NOC Watch: OxyNEO, Staxyn...Toromont Industries Recognized as a Finalist for the Inaugural Benefits Canada Drug Plan Management Award. View post
IN THIS ISSUE...Under the microscope: are plans overpaying for newer therapies for Diabetes...Biosimilar Chorionic Gonadotropin in Quebec – Clarification...NOC Watch: Jevtana, Generic Zolmitriptan, Benlysta...FEATURE: Money down the drain - nobody benefits from non-adherence View post
IN THIS ISSUE...HIV treatment: earlier is better...NOC Watch: Abstral, Gelnique...FEATURES: Carpe Diem – Savings with Generics in 2011...Drug plans or dealer supply chains? View post
2013 MHCSI Pharmacy Benefits Round Table -(February 2013) - It’s time to get practical. Plan sponsors need actionable advice that takes into consideration their unique employee groups. Specifically, they want to... Download PDF
Canadian students abusing Adderall to get edge in studying -CTVNews.ca (Feb. 4, 2013) - Doctors in Canada are concerned that university and college students are abusing a prescription drug that contains amphetamines to stay awake and... View post